Home > Drug Search >
  • company_query: Beth Israel Deaconess Medical Center
  •   > 
Drug Filter
Category:
chemistry (26) biology (14)
Status:
Approved (5) Phase Ⅲ (8) Phase Ⅱ (16) Phase Ⅰ (11)
Clinical Stage:
Pending (7) Active (19) Discontinued (9)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (6) Recombinant cytokines (1) Whole antibody (2)
Indication:
Non-alcoholic steatohepatitis (1) Acute bacterial skin and skin structure infections (ABSSSI) (1) Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (4) Anaesthetic (1) Bladder cancer (1) Cancer related pain (1) Chronic lymphocytic leukemia (CLL) (1) Community-acquired bacterial pneumonia (CABP) (1) Hookworm infections (1) Contrast agents (4) Diabetic nephropathy (1) Facial acne vulgaris (1) Follicular lymphoma (1) HCV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Leukemia (1) Major depressive disorder (MDD) (1) Melanoma (3) Moderate-to-severe acute pain (1) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (2) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (3) Postoperative pain (1) Prostate cancer (3) Psoriasis (1) Sedation (2) Solid tumours (5) Thyroid cancer (1) Reperfusion injury (1) Colorectal cancer (3) Stroke (3) Cholecystitis (1) Malaria (1) Renal carcinoma (1) Glioblastoma (3) Glioma (1) Diffuse large B cell lymphoma (1) Liver cancer (1) Neurological disease (1) Cachexia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top